‘Science Speaks’ Examines Findings From New Study On Geographic Differences In Hepatitis C Incidence Among People Who Inject Drugs

Center for Global Health Policy’s “Science Speaks”: Where harm reduction policies went up, hepatitis C incidence went down, study finds
Antigone Barton, senior editor and writer of “Science Speaks,” discusses findings from research published in Clinical Infectious Diseases examining differences in hepatitis C infection trends among people who inject drugs across cities in North America, Australia, and the Netherlands. Barton notes, “Authors of the study … say the differences in incidence reflect differences in policies to reduce the harm of injecting drug use…” (5/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.